<!DOCTYPE html>
<html>
<head>
    <title>   </title>
</head>
<body>

<script src="ngl.js"></script>



<b> 4CMH </b>
<br>
<p> TITLE     CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY        
TITLE    2 SAR650984                                                            
 </p>
<p> resolution: 1.53 </p>
<p> chains: A </p>
<p> residues: 45-300 </p>
<p> JRNL        TITL   SAR650984, A NOVEL HUMANIZED CD38-TARGETING ANTIBODY,        
JRNL        TITL 2 DEMONSTRATES POTENT ANTITUMOR ACTIVITY IN MODELS OF MULTIPLE 
JRNL        TITL 3 MYELOMA AND OTHER CD38+ HEMATOLOGIC MALIGNANCIES.            
 </p>
<p> JRNL        REF    CLIN. CANCER RES.             V.  20  4574 2014              
 </p>
<p> <a href="https://doi.org/10.1158/1078-0432.CCR-14-0695"> 10.1158/1078-0432.CCR-14-0695 </a>  </p>
<p> <a href="https://www.rcsb.org/structure/4CMH"> RCSB: 4CMH </a>  </p>



<b> 5F1K </b>
<br>
<p> TITLE     HUMAN CD38 IN COMPLEX WITH NANOBODY MU1053                            
 </p>
<p> resolution: 2.30 </p>
<p> chains: A/B </p>
<p> residues: 45-300 </p>
<p> JRNL        TITL   IMMUNO-TARGETING THE MULTIFUNCTIONAL CD38 USING NANOBODY     
 </p>
<p> JRNL        REF    SCI REP                       V.   6 27055 2016              
 </p>
<p> <a href="https://doi.org/10.1038/SREP27055"> 10.1038/SREP27055 </a>  </p>
<p> <a href="https://www.rcsb.org/structure/5F1K"> RCSB: 5F1K </a>  </p>



<b> 3RAJ </b>
<br>
<p> TITLE     CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF   
TITLE    2 ANTIBODY HB7                                                         
 </p>
<p> resolution: 3.04 </p>
<p> chains: A </p>
<p> residues: 46-300 </p>
<p> JRNL        TITL   ENGINEERING A NOVEL CYTOSOLIC FORM OF CD38 FOR CYCLIC        
JRNL        TITL 2 ADP-RIBOSE DEPENDENT SIGNALING                               
 </p>
<p> JRNL        REF    TO BE PUBLISHED                                              
 </p>
<p> <a href="https://doi.org/None"> None </a>  </p>
<p> <a href="https://www.rcsb.org/structure/3RAJ"> RCSB: 3RAJ </a>  </p>



<b> 5F1O </b>
<br>
<p> TITLE     HUMAN CD38 IN COMPLEX WITH NANOBODY MU551                             
 </p>
<p> resolution: 2.20 </p>
<p> chains: A </p>
<p> residues: 46-300 </p>
<p> JRNL        TITL   IMMUNO-TARGETING THE MULTIFUNCTIONAL CD38 USING NANOBODY     
 </p>
<p> JRNL        REF    SCI REP                       V.   6 27055 2016              
 </p>
<p> <a href="https://doi.org/10.1038/SREP27055"> 10.1038/SREP27055 </a>  </p>
<p> <a href="https://www.rcsb.org/structure/5F1O"> RCSB: 5F1O </a>  </p>



<b> 5F21 </b>
<br>
<p> TITLE     HUMAN CD38 IN COMPLEX WITH NANOBODY MU375                             
 </p>
<p> resolution: 1.90 </p>
<p> chains: A </p>
<p> residues: 46-300 </p>
<p> JRNL        TITL   IMMUNO-TARGETING THE MULTIFUNCTIONAL CD38 USING NANOBODY     
 </p>
<p> JRNL        REF    SCI REP                       V.   6 27055 2016              
 </p>
<p> <a href="https://doi.org/10.1038/SREP27055"> 10.1038/SREP27055 </a>  </p>
<p> <a href="https://www.rcsb.org/structure/5F21"> RCSB: 5F21 </a>  </p>



</body>
</html>